D&D CEO Orlando Agrippa backs the healthcare potential
As the Government promises to invest £20.5bn to improve the NHS, who else sees the “healthcare potential?” by Orlando Agrippa, CEO of Draper and Dash
Underfunded and pushed to breaking point, the NHS is set to receive a cash boost that will help alleviate the strains it’s currently under. A financial commitment from the government of £20.5bn has been promised to improve patient flow, patient access, and overall patient care. In a speech at a Draper & Dash (D&D) healthcare customer site, the Royal Free hospital in London, the Prime Minister confirmed the government would set aside extra funds for the health service by 2023. As the political uncertainty of Brexit looms, and questions about how this new legislation will get funded, it is critical to see investment and support from the government. Furthermore, it will require support from the industry and innovation from technology providers to make the health service more efficient. As the debate continues, and hospitals welcome the news, one thing remains constant – people, organisations, and governments are still investing in what I describe as the “healthcare potential”.
In the most basic form, our society needs healthcare. We all need healthcare. We all know of someone that benefited from an institution such as the NHS. Many people have experienced direct involvement, or family members or ancestors that have worked for the NHS. The concept often goes beyond the sheer cost or ownership of the NHS. The NHS is, in fact, a necessity and part of our heritage. In short, the NHS has become part of our DNA for 70 years and those three letters are never too far from the news. Because of this, investment, commitment, and innovation will continue to be top of the agenda for the health services – because as a society, we need it.
It is no secret that the NHS could perform better. Its primary responsibility is in patient care, but this is intrinsically linked to a multitude of other factors. These factors contribute to an inefficient NHS. It could be argued that inefficiencies happen through archaic processes and out-of-date systems that cost the NHS money. With programs in place, like NHS Digital, and a renewed focus on going digital, NHS providers are exploring the possibilities of technology driving better patient flow, improved patient safety and, better business outcomes. In an age of “Industry 4.0”, it is surely automation, cloud, artificial intelligence, robotics and digital adoption that will ease the conditions in the NHS and technology providers may hold the key to making the most of the financial investment that continues to be made available. This does, however, cost more than just money. It needs significant commitment in R&D and innovation from organisations that can deliver real change.
Major investment from technology giants like Apple, Google and Amazon further cement the growing trend that the healthcare potential is at a tipping point. That is, the latency in adoption will soon be combatted by artificial intelligence (AI), machine learning and new methods of patient access and patient flow. For example, Google recently announced plans to combat disease by utilizing the power of AI. That is, to allow machines to analyze, predict and prescribe better ways of managing serious illnesses. The approach Google is taking is to make data become the key component by making it available through interoperable platforms and systems to unlock the healthcare potential. In fact, Google is so committed that their CEO, Sundar Pichai said “so tomorrow, if AI can shape healthcare, it has to work through the regulations of healthcare … In fact, I see that as one of the biggest areas is where the benefits will play out for the next 10 – 20 years.”